JUN and acute kidney injury: Administration of a small molecule inhibitor of AP-1 or the senolytic agent ABT-263 reduced expression of genes consistent with an inflammatory tubular cell phenotype and ameliorated inflammation and fibrosis in murine models of transition from acute kidney injury (AKI) to CKD.